Navigation Links
Valeant Pharmaceuticals Receives FTC Second Request Under Hart-Scott-Rodino
Date:8/11/2014

QUEBEC, Aug. 11, 2014 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) announced that the Company has received a request for additional information from the Federal Trade Commission ("FTC") in connection with Valeant's proposed acquisition of Allergan, Inc. (NYSE: AGN).  The information request was issued under notification requirements of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"). 

The effect of the second request is to extend the waiting period imposed by the HSR Act until 30 days after Valeant has substantially complied with the request, unless that period is terminated sooner by the FTC.  Valeant is cooperating fully with the FTC's review and will take all actions necessary to obtain regulatory approval for the proposed transaction on a timely basis.

About Valeant Pharmaceuticals International, Inc.Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, eye health, neurology  and branded generics. More information about Valeant can be found at www.valeant.com.

Forward-looking Statements This communication may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and Canadian securities laws.  These forward-looking statements include, but are not limited to, statements regarding Valeant's offer to acquire Allergan, its financing of the proposed transaction, its expected future performance (including expected results of operations and financial guidance), and the combined company's future financial condition, operating results, strategy and plans.  Forward-looking statements may be identified by the use of the words "anticipates," "expects," "intends,
'/>"/>

SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Valeant Pharmaceuticals And Pershing Square Respond To Frivolous Allergan Lawsuit
2. Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results
3. Valeant Pharmaceuticals Files An Official Complaint With The Autorite Des Marches Financiers About Allergans False And Misleading Statements
4. Valeant Pharmaceuticals Contacts Quebec and U.S. Regulators About Allergans False and Misleading Statements
5. Valeant Pharmaceuticals Files Investor Presentation
6. Valeant Pharmaceuticals Submits HSR Filing Relating To Proposed Acquisition Of Allergan
7. Valeant Pharmaceuticals Completes Sale Of Filler And Toxin Assets To Galderma
8. Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc.
9. Presentation Schedules, Stock Movements, Agreements, and New Appointments - Research Report on Celgene, Merck, Bristol-Myers, Valeant, and Mylan
10. Valeant Pharmaceuticals To Present At Industry Conferences
11. Valeant Pharmaceuticals Agrees to Acquire Solta Medical for $2.92 Per Share in Cash
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... Pharma Major Lupin Limited today announced the acquisition of ... subject to certain closing conditions. The acquisition marks ... 765 billion in sales, placing it as one of the ... Health). For over a decade, Russian pharmaceutical market recorded double ... Russia to be one of the ...
(Date:7/2/2015)... , July 2, 2015  Konica Minolta, Inc. (Konica ... that it has acquired Sawae Technologica Ltda., an X-ray ... Brazil , through its Brazilian healthcare sales company, ... Local Brazil market ... increasing population exceeding 200 million, significant healthcare technical advancements ...
(Date:7/2/2015)... , South Korea, July 2, 2015 ALPINION MEDICAL ... new E-CUBE Series ultrasound system. Developed to enhance user ... areas, the E-CUBE 15 EX produces superb image quality. ... performance in women,s health, general imaging, and shared service ... The latest in the renowned E-CUBE Series, the E-CUBE ...
Breaking Medicine Technology:Lupin Acquires Biocom in Russia 2Lupin Acquires Biocom in Russia 3Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 2Konica Minolta Acquires Sawae, Enhancing Digital X-ray Diagnostic Imaging Systems in Brazil 3E-CUBE 15 EX from ALPINION Enhances User Experience and Patient Care 2E-CUBE 15 EX from ALPINION Enhances User Experience and Patient Care 3
... Inc. (OTC Bulletin Board: CGNH), developer of the ultra-sensitive QL Care™ Point-Of-Care (POC) ... that the Company,s ticker symbol has been changed back to "CGNH" and the ... , , ... , , ...
... , July 22 Charter Business customers in Wisconsin ... program for rural health care that the Federal Communications Commission (FCC) proposes ... , , ... FCC last week would make permanent the Rural Health Care Pilot Program, ...
Cached Medicine Technology:CardioGenics Holdings Inc. Receives New Ticker Symbol 2Charter's Wisconsin, Oregon Customers Already Benefiting From FCC's Efforts to Expand Medical Services via Broadband 2Charter's Wisconsin, Oregon Customers Already Benefiting From FCC's Efforts to Expand Medical Services via Broadband 3Charter's Wisconsin, Oregon Customers Already Benefiting From FCC's Efforts to Expand Medical Services via Broadband 4
(Date:7/2/2015)... CORNER, VA (PRWEB) , ... July 02, 2015 ... ... innovative technology solutions and management consulting services to the federal government, has announced ... five-year, Indefinite-Delivery, Indefinite-Quantity (IDIQ), Business Management Office Support Services (BMOSS) contract not to ...
(Date:7/2/2015)... (PRWEB) , ... July 02, 2015 , ... Hand sanitizers ... the current summer flu season, according to fresh water advocate and radio host Sharon ... the hands. Kleyne cautions that for maximum effectiveness, hand sanitizers must be applied correctly ...
(Date:7/2/2015)... ... July 02, 2015 , ... Throughout the month of April, Casey’s ... Tag” campaign. On Tuesday, July 7, Casey’s General Stores Chairman and CEO, Bob ... For The Warriors® is a national nonprofit dedicated to restoring a sense of self, ...
(Date:7/2/2015)... , ... July 02, 2015 , ... ... and development solutions for drugs, biologics and consumer health products, today announced that ... , Dr. Irmgard Neuper is the new General Manager at Catalent’s Schorndorf facility, ...
(Date:7/2/2015)... Lind, CA (PRWEB) , ... July 02, 2015 , ... ... PhD, QC manager, have adopted Lean methodology in their QC laboratory for enhanced workflow. ... Certified Lean Six Sigma Laboratory within the GE Healthcare Diagnostic Imaging network. ...
Breaking Medicine News(10 mins):Health News:Octo Consulting Group Awarded IDIQ Contract for SEC Business Management Support 2Health News:Summer flu season hand sanitizers are most effective when correctly applied reports fresh water advocate Sharon Kleyne 2Health News:Summer flu season hand sanitizers are most effective when correctly applied reports fresh water advocate Sharon Kleyne 3Health News:Casey’s General Stores to Present Donation from “Dog Tag” Campaign to Hope For The Warriors® 2Health News:Casey’s General Stores to Present Donation from “Dog Tag” Campaign to Hope For The Warriors® 3Health News:Catalent Makes Two Key European Appointments in Oral Dose Manufacturing 2Health News:GE Healthcare Webinar Spotlights GE’s Own, Internal QC Lab Enhancements with Six Sigma 2Health News:GE Healthcare Webinar Spotlights GE’s Own, Internal QC Lab Enhancements with Six Sigma 3
... and efficacy of first FDA-approved nebulized ... COPD -, NAPA, Calif., May 16 Dey, ... given at the International,Conference of the American Thoracic Society ... Center. One of the presentations details the,effects on dyspnea ...
... mastectomy (total breast removal) for early-stage breast cancer has ... in Rochester. The increase follows a steady decline during ... for this increase are unclear. But they have determined ... resonance imaging (MRI) prior to surgery to treat early-stage ...
... sooner if therapy is working , , FRIDAY, May 16 ... levels of circulating tumor cells can help doctors more ... with metastatic breast cancer, according to a Georgetown University ... weeks, and sometimes months, to determine if a particular ...
... /Xinhua-PRNewswire-FirstCall/ --,Shengtai Pharmaceutical, Inc. (OTC Bulletin Board: SGTI) ... distributor,of high-quality, pharmaceutical grade glucose products in China, ... March 31, 2008., Third Quarter of ... to $20.7 million -- Gross profit rose ...
... May 16 IDM Pharma, Inc.,(Nasdaq: IDMI ... Company,s lead product candidates will be made at ... annual meeting. Data presented,at the meeting will support ... L-MTP-PE, as well as patients with non-small lung,cancer ...
... wake of divorce, illness, violence and other problems that ... experience temporary separations from one or both parents before ... May/June issue of Ambulatory Pediatrics, a new, community-wide study ... at increased risk for learning difficulties and that these ...
Cached Medicine News:Health News:Clinical Trial Data for Perforomist(TM) Inhalation Solution to be Presented at ATS on May 20, 2008 2Health News:Clinical Trial Data for Perforomist(TM) Inhalation Solution to be Presented at ATS on May 20, 2008 3Health News:Clinical Trial Data for Perforomist(TM) Inhalation Solution to be Presented at ATS on May 20, 2008 4Health News:Clinical Trial Data for Perforomist(TM) Inhalation Solution to be Presented at ATS on May 20, 2008 5Health News: Mastectomies on the rise and MRI use may explain part of the trend, say Mayo researchers 2Health News: Mastectomies on the rise and MRI use may explain part of the trend, say Mayo researchers 3Health News:Blood Test Helps Docs Assess Breast Cancer Treatment 2Health News:Shengtai Pharmaceutical, Inc. Reports Third Quarter Results of Fiscal Year 2008 2Health News:Shengtai Pharmaceutical, Inc. Reports Third Quarter Results of Fiscal Year 2008 3Health News:Shengtai Pharmaceutical, Inc. Reports Third Quarter Results of Fiscal Year 2008 4Health News:Shengtai Pharmaceutical, Inc. Reports Third Quarter Results of Fiscal Year 2008 5Health News:Shengtai Pharmaceutical, Inc. Reports Third Quarter Results of Fiscal Year 2008 6Health News:Shengtai Pharmaceutical, Inc. Reports Third Quarter Results of Fiscal Year 2008 7Health News:Shengtai Pharmaceutical, Inc. Reports Third Quarter Results of Fiscal Year 2008 8Health News:Shengtai Pharmaceutical, Inc. Reports Third Quarter Results of Fiscal Year 2008 9Health News:Shengtai Pharmaceutical, Inc. Reports Third Quarter Results of Fiscal Year 2008 10Health News:Shengtai Pharmaceutical, Inc. Reports Third Quarter Results of Fiscal Year 2008 11Health News:Shengtai Pharmaceutical, Inc. Reports Third Quarter Results of Fiscal Year 2008 12Health News:IDM Pharma Announces Presentations at 44th American Society of Clinical Oncology Annual Meeting 2Health News:IDM Pharma Announces Presentations at 44th American Society of Clinical Oncology Annual Meeting 3Health News:Separation from mom, dad linked with learning trouble in kids 2Health News:Separation from mom, dad linked with learning trouble in kids 3
... Wet-Field Coagulator provides precise episcleral, intrascleral, ... tissue trauma. Controlled Rf diathermy delivers ... line of bipolar Eraser instruments, forceps ... features that ensure a high level ...
... Accu-Temp Cauteries provide a broad ... in a wide variety of ophthalmic ... packaged sterile, complete with a safety ... "off " position when not in ...
... a broad selection of tip styles ... of ophthalmic procedures. Each single use ... a safety cap to lock switch ... not in use, and carries a ...
... Accu-Temp Cauteries provide a broad selection ... a wide variety of ophthalmic procedures. ... sterile, complete with a safety cap ... " position when not in use, ...
Medicine Products: